Inventor · disambiguated record
Li Zhang
Also filed as: ZHANG LI · Zhang li qin
28 granted patents·28 pending applications·1,556 citations·filing 2001–2024
96Inventor score
Files withCELLULAR BIOMEDICINE GROUP INC7REGENERON PHARMA5CELLULAR BIOMEDICINE GROUP HK LTD4NANJING UNIVERSITY OF TECHNOLOGY4SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD4
Top patents by PatentIndex Score
56 records- 0198US8366787B2Hybrid biologic-synthetic bioabsorbable scaffoldsDEPUY PRODUCTS INC·Filed 2002·Granted Feb 5, 2013·1.1k cites·12 claims
- 0296US11472858B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Oct 18, 2022·7 cites·4 claims
- 0395US11618778B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 4, 2023·7 cites·6 claims
- 0495US11608369B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Mar 21, 2023·7 cites·6 claims
- 0594US11066457B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Granted Jul 20, 2021·8 cites·8 claims
- 0694US9409990B2Methods of inhibiting tumor growth by antagonizing IL-6 receptorREGENERON PHARMA·Filed 2014·Granted Aug 9, 2016·12 cites·24 claims
- 0794US7919184B2Hybrid nanoparticlesMOHAPATRA SATISH C·Filed 2007·Granted Apr 5, 2011·300 cites·18 claims
- 0892US11358991B2Heme sequesting peptides and uses thereforUNIV TEXAS·Filed 2020·Granted Jun 14, 2022·2 cites·34 claims
- 0992US7732126B2Integrin CD18 is a novel stromal stem cell marker and functions to promote osteogenesisUNIV MARYLAND·Filed 2005·Granted Jun 8, 2010·35 cites·20 claims
- 1088US11498973B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Nov 15, 2022·1 cites·4 claims
- 1188US8043620B2Wise binding agents and epitopesAMGEN INC·Filed 2008·Granted Oct 25, 2011·13 cites·5 claims
- 1282US11142581B2BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2020·Granted Oct 12, 2021·1 cites·7 claims
- 1381US2023242613A1Construction of chimeric antigen receptor targeting cd20 antigen and activity identification of engineered t cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 1478US2024309337A1Method for large-scale preparation of purified preparation of recombinant lentiviral vector at gmp gradeABELZETA INC·Filed 2024·Application pending·0 cites
- 1577US6953576B2Method of modulating tumor immunityUNIV HEALTH NETWORK·Filed 2001·Granted Oct 11, 2005·7 cites·5 claims
- 1676US12168678B2Heme sequesting peptides and uses thereforUNIV TEXAS·Filed 2022·Granted Dec 17, 2024·0 cites·27 claims
- 1776US11845962B2Method for large-scale production of lentivirus by using GMP-level serum-free suspension cellsSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2019·Granted Dec 19, 2023·2 cites·10 claims
- 1875US12180513B2Method for large-scale production of lentivirus by using GMP-level serum-free suspension cellsSHANGHAI ABELZETA LTD·Filed 2023·Granted Dec 31, 2024·0 cites·20 claims
- 1975US2025084386A1Method for large-scale production of lentivirus by using gmp-level serum-free suspension cellsSHANGHAI ABELZETA LTD·Filed 2024·Application pending·0 cites
- 2074US2024190973A1Anti-fgfr2 antibodies and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2172US11866502B2Anti-FGFR2 antibodies and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Jan 9, 2024·0 cites·65 claims
- 2267US8309092B2Wise binding agents and epitopesQIAN XUEMING·Filed 2011·Granted Nov 13, 2012·2 cites·5 claims
- 2367US2023053305A1BCMA-Targeted Chimeric Antigen Receptor as well as Preparation Method Therefor and Application ThereofSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2022·Application pending·0 cites
- 2466US2024141361A1Gene circuit, rna delivery system and use thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2023·Application pending·0 cites
- 2566US2024141347A1Rna delivery system for treatment of huntington's diseaseNANJING UNIVERSITY OF TECHNOLOGY·Filed 2023·Application pending·0 cites
- 2666US2024141344A1Rna plasmid delivery system and application thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2023·Application pending·0 cites
- 2766US2024229027A1Nucleic acid delivery system and application thereofNANJING UNIVERSITY·Filed 2023·Application pending·0 cites
- 2865US12018293B2Method for large-scale preparation of purified preparation of recombinant lentiviral vector at GMP gradeABELZETA INC·Filed 2019·Granted Jun 25, 2024·0 cites·8 claims
- 2964US8722623B2Compositions and methods utilizing fibrin beta chain fragmentsMEDVED LEONID·Filed 2008·Granted May 13, 2014·1 cites·17 claims
- 3063US2024141380A1Viral vector-based rna delivery system and use thereofNANJING UNIVERSITY OF TECHNOLOGY·Filed 2023·Application pending·0 cites
- 3163US2013122003A1Methods of inhibiting tumor growth by antagonizing il-6 receptorREGENERON PHARMA·Filed 2012·Application pending·0 cites
- 3261US7754433B2Identification of high affinity molecules by limited dilution screeningAMGEN FREMONT INC·Filed 2002·Granted Jul 13, 2010·3 cites·20 claims
- 3360US12344835B2Penicillium oxalicum SDF-25 strain and application thereofUNIV HEBEI SCIENCE & TECH·Filed 2021·Granted Jul 1, 2025·0 cites·5 claims
- 3460US2017022279A1Methods of inhibiting tumor growth by antagonizing il-6 receptorREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 3559US12377040B1Rhodosorus marinus and application thereof in preparing facial masksUNIV HAINAN NORMAL·Filed 2024·Granted Aug 5, 2025·0 cites·1 claims
- 3659US12305164B2Escherichia coli k-12 MG1655 BLBYZT6 and application thereofBAOLINGBAO BIOLOGY CO LTD·Filed 2024·Granted May 20, 2025·0 cites·9 claims
- 3756US2023141382A1Compositions for preservation of viral vectorsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 3855US2024174752A1Modulating product quality of asymmetric multispecific antibodies through the use of temperatureAMGEN INC·Filed 2022·Application pending·0 cites
- 3955US2005169942A1Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeuticsALLERGAN INC·Filed 2004·Application pending·0 cites
- 4055US2023340398A1Methods for lysing bacterial cellsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 4154US2023304108A1Method for determining titer of rna viral vectorsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 4252US10584350B2Structurally modified COI1UNIV MICHIGAN STATE·Filed 2017·Granted Mar 10, 2020·0 cites·28 claims
- 4351US9732388B2Nucleic acid markers for rapid diagnosis of kawasaki disease and kit for detection of the nucleic acid markersGUANGZHOU SAGENE BIOTECH CORP·Filed 2014·Granted Aug 15, 2017·0 cites·3 claims
- 4451US2023416309A1Fusion protein and application thereofJIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION PUBLIC HEALTH RES INSTITUTE OF JI·Filed 2021·Application pending·0 cites
- 4551US2022000932A1Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat strokeFORD HENRY HEALTH SYSTEM·Filed 2019·Application pending·0 cites
- 4651US2020297763A1Pluripotent stem cell-derived macrophage capable of targeting tumor cells and preparation method thereofUNIV ZHEJIANG·Filed 2020·Application pending·0 cites
- 4749US2023144447A1Cd22-targeted chimeric antigen receptor, preparation method therefor and application thereofSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2021·Application pending·0 cites
- 4849US2023257704A1Methods for preparation of immune cellsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 4947US2022356473A1Sirna for inhibiting htt gene expression, and precursor and application thereofEXORNA BIOSCIENCE NANJING CO LTD·Filed 2020·Application pending·0 cites
- 5046US2023407335A1Methods for Preparing Genetically Modified CellsSHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Li Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →